CSI Market
Sign In | Register

Adc Therapeutics Sa (ADCT) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ADCT quarterly Cash Flow →
Examining cash flow movements between Adc Therapeutics Sa and Dec 31 2021 reveals how Dec 31 2025 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-142.60
Depreciation & amortization0.71
Amortization of Other Assets29.13
Special charges0.00
Accountig change5.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase2.38
Effect of exchange rate0.00
Sale of Business0.00
Share-based Compensation-0.01
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-0.67
Adjustments For Sharebased Payments-
Adjustments For Depreciation Expense Property Plant And Equipment-
Adjustments For Depreciation Expense Of Right Of Use Assets-
Adjustments For Amortisation Expense And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss Intangible Assets-
Share Of Profit Loss Of Joint Ventures Accounted For Using Equity Method-
Adjustments For Increase Decrease In Non Current Net Defined Benefit Liability-
Adjustments For Finance Income-
Adjustments For Finance Costs-
Adjustments For Income Tax Expense-
Cash Flows From Used In Operations Before Changes In Working Capital-
Adjustments For Decrease Increase In Other Current Assets-
Adjustments For Increase Decrease In Contract Liabilities-
Adjustments For Increase Decrease In Trade And Other Payables-
Adjustments For Increase Decrease In Other Liabilities-
Deferred Royalty Obligation Cumulative Catch Up Adjustment-22.21
Pension Expense Reversal Of Expense Noncash-
Operating Lease Right Of Use Asset Amortization Expense6.70
Increase Decrease In Operating Lease Liability-2.50
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable8.79
Increase (Decrease) in Accounts Payable, Trade-9.04
Increase (Decrease) in Accrued Liabilities-7.42
Payments for (Proceeds from) Other Deposits-0.66
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital-5.23
Other Noncash Income (Expense)-0.30
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.51
Discontinued operations0.00
Net Cash flow from Operating Activities-141.17
Investing Activities
Capital Expenditures0.26
Sale of Capital Items0.00
Short-term investments liq.0.00
Short-term investments acq.0.00
Proceeds from other investments0.00
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Purchases of Investments0.00
Purchases of non-current assets0.00
Acquisition net of cash acquired0.00
Investment in affiliate0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Notes receivable0.00
Other0.00
Other Net0.66
Discontinued operations0.00
Net Cash Flow from Investing Activities0.40
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock86.28
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock65.37
Discontinued Operations0.00
Other financing activities net1.51
Other net-1.51
Proceeds From Royalties Received Net Of Transaction Costs-
Dividends paid to minority interests0.00
Dividends paid0.00
Net Cash Flow from Financing Activities150.95
Effect of exchange rate on cash flow0.31
Discontinued operations0.00
Free Cash Flow-140.91
Total Cash Flow10.17
4 historic quarters locked

Sign in to unlock the full Adc Therapeutics Sa cash flow history.

Sign In Create Free Account

About Adc Therapeutics Sa Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 10, 2026
  • Source: adc-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-016491

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License